about
Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected PeptidesFour-Week Repeated Intravenous Dose Toxicity and Toxicokinetic Study of TS-DP2, a Novel Human Granulocyte Colony Stimulating Factor in Rats.Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.A dimeric peptide with erythropoiesis-stimulating activity uniquely affects erythropoietin receptor ligation and cell surface expression.Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performance.Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation.Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.Recombinant Proteins and Monoclonal Antibodies.Bone marrow drives central nervous system regeneration after radiation injury.Dynamic cellular phynotyping defines specific mobilization mechanisms of human hematopoietic stem and progenitor cells induced by SDF1α versus synthetic agents.Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM).Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator ProductLaboratory Medicine to improve biological therapeutic treatment
P2860
Q36198586-ACAAD081-BE5E-4D5A-8DA7-408C9911709EQ36574189-E39A6A56-2C62-4BB5-8C97-91367A3B2228Q38613025-BD027CA3-03F8-4C29-B733-05EF0F512E76Q38771395-A9C208E7-9B55-468C-8621-AFD05F9BB9DEQ39385304-6B3A9124-3563-4E33-B0A9-FF0D031B011CQ40561903-AB108738-0125-4A3C-8773-FDA683E1E35FQ42363042-61871EE5-9D67-4DC1-9101-F29ED20BEB2AQ47602370-25EFD084-1DA4-40B1-8D98-C2ABD5E08463Q47935377-ED4A9DDA-1295-4692-946C-16D945823679Q48138880-FC251672-0F55-4798-8895-F2163DF1D111Q55111318-6134DBFF-0CE0-4547-B3FA-371B1F56AC8DQ57049370-2649760A-52D2-41BC-B701-E483AE87BA9CQ58055739-386C6117-4EDE-4CBA-AC21-E4E9DECF3E16
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
G-CSF: filgrastim, lenograstim and biosimilars.
@en
type
label
G-CSF: filgrastim, lenograstim and biosimilars.
@en
prefLabel
G-CSF: filgrastim, lenograstim and biosimilars.
@en
P2860
P1476
G-CSF: filgrastim, lenograstim and biosimilars.
@en
P2093
Karl Welte
P2860
P304
P356
10.1517/14712598.2014.905537
P407
P577
2014-04-07T00:00:00Z